Menopause hormone therapy can be given to women with CKD. The regimen should
be selected on the basis of patient preference and the individual's cardiovascular risk. The dose of hormonal and
non-hormonal preparations should be adjusted in accordance with the patient's creatinine clearance. The
management of a postmenopausal woman with CKD should focus on lifestyle advice as well as regular monitoring
of the main cardiovascular risk factors and evaluation of bone mineral density. Tailored multidisciplinary
advice should be given to women with comorbidities such as diabetes, dyslipidemia, and hypertension. Management
of osteoporosis should be based on the severity of the CKD.

全文請點我